The National One Stop Shop - a national platform for health and medical research

The Commission is conducting national consultations on behalf of all jurisdictions to scope the requirements for a national health and medical research approvals platform – a National One Stop Shop.

The aim of the National One Stop Shop is to make it easier for patients, researchers, industry representatives and sponsors to find, conduct, participate and invest in high quality and ethical research in Australia.


The concept for the National One Stop Shop was developed by the Australian Government Department of Health and the Clinical Trials Project Reference Group and presents a significant opportunity to achieve a national, interconnected, rapid and streamlined approvals platform to:

  • address long-standing challenges with duplication, delays, navigation and fragmentation as a result of different research ethical approval and local site authorisation systems in the jurisdictions; separate processes for Therapeutic Goods Administration (TGA) notifications; a separate process for registration on the Australian and New Zealand Clinical Trials Registry; separate processes for other jurisdiction-specific and therapy-specific approvals and authorisations and, the absence of individualised and fragmented operational monitoring and reporting approaches
  • enhance patient access to state-of-the-art treatments
  • improve health outcomes
  • contribute to the innovation economy and a self-improving health system
  • strengthen Australia’s global positioning in health and medical research.


Creating sustainable efficiencies within the heath and human research sector through a single national, interconnected, rapid and streamlined world-leading approvals platform in collaboration with all jurisdictions that will:

  • provide a cross-jurisdictional ethics approval and site-specific authorisation platform that incorporates key application, notification and approval systems
  • incorporate the Clinical Trials Notification and Clinical Trials Approval schemes administered by the TGA
  • include an embedded and automated next-generation national clinical trials registry
  • provide sophisticated monitoring and reporting functionality for different users.

Options for improving research participation through a related community volunteer recruitment portal, the National Clinical Trials Front Door will also be considered through the consultation process. This includes mechanisms that facilitate access to third party participant recruitment providers. 

Additionally, the National One Stop Shop will:

  • embed the National Clinical Trials Governance Framework accreditation obligations and automate data/reports/processes to support the accreditation process
  • assist all governments to respond to areas of need in a rapid, coordinated and strategic manner based on real-time, accurate information regarding trial activity and site capability
  • aim to extend beyond the public and private hospital sector to incorporate the university, primary care and independent medical research sectors
  • protect data integrity and adhere to data security requirements.

The project advisory group chaired by Professor Ian Chubb AC, former Chief Scientist and clinical trial participant has been established to guide the consultation process.

Initial consultations were undertaken with the Chair and the jurisdictions from June 2021. Currently, targeted consultations with state and territory health departments and health and medical research organisations are underway to build our understanding of existing systems and jurisdictional needs. These will be followed by broad consultations with clinicians, consumers, healthcare providers and professional bodies, on the needs and expectations of the sector to scope the requirements for a national health and medical research platform – a National One Stop Shop.

The Commission is inviting submissions and participation in the initial phase of sector-wide consultations from October - 17 December 2021. 

Register your interest

Click on the link and complete the required information to receive updates on how to be involved.

If you have any questions relating to this consultation, please contact